| mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
0.015 |
0.9 |
| mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
-0.0041 |
0.9 |